CTNNBIP1通过促进β-catenin/TCF复合物下游基因转录调控角质形成细胞增殖
该研究通过分析银屑病皮损与非皮损皮肤的公共芯片和RNA-seq数据,筛选出CTNNBIP1在银屑病皮损中显著下调,并经临床样本和IMQ小鼠模型验证。机制上,CTNNBIP1沉默促进β-catenin核转位及TCF4转录活性,上调c-Myc和cyclin D1,从而抑制角质形成细胞凋亡并促进增殖。
要点
- CTNNBIP1在银屑病皮损中表达显著下调,且经治疗后可回升。
- CTNNBIP1沉默通过激活β-catenin/TCF复合物下游c-Myc和cyclin D1促进角质形成细胞增殖。
- CTNNBIP1可能成为银屑病角质形成细胞异常增殖的潜在调控靶点。
核心结论
- CTNNBIP1是银屑病中异常下调的基因,其沉默通过促进β-catenin/TCF复合物下游基因转录扰乱角质形成细胞增殖。
研究设计与样本
- 研究整合7套银屑病皮损与非皮损皮肤microarray mRNA表达谱和3套RNA-seq数据进行在线分析。
- 在银屑病患者及IMQ小鼠模型皮肤组织中用RT-PCR、免疫印迹和IHC检测CTNNBIP1表达。
- 在HaCaT细胞中用MTT、EdU、流式细胞术、IF、荧光素酶报告基因和免疫印迹检测CTNNBIP1对增殖、凋亡及β-catenin/TCF复合物的影响。
主要发现
- 在线数据与实验结果均显示CTNNBIP1在银屑病皮损皮肤组织中较非皮损皮肤组织显著下调。
- 经不同治疗后银屑病皮损皮肤组织中CTNNBIP1表达可回升。
- IMQ诱导的小鼠银屑病样皮炎中,CTNNBIP1沉默进一步加重银屑病表型。
- HaCaT细胞中CTNNBIP1沉默显著抑制细胞凋亡并促进细胞增殖。
- CTNNBIP1沉默促进β-catenin核转位、增强TCF4转录活性并增加c-Myc、cyclin D1及ki-67表达,且皮损组织中c-Myc和cyclin D1与CTNNBIP1呈负相关。
临床怎么用
- CTNNBIP1下调及β-catenin/TCF下游c-Myc、cyclin D1上调可作为银屑病角质形成细胞异常增殖的分子线索。
- CTNNBIP1表达经治疗后可回升,提示其或可作为反映治疗反应的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During psoriasis initiation and development, deregulations in signalling pathways and gene expression are observed. METHODS: Herein, we downloaded seven sets of microarray mRNA expression profiles showing differentially expressed genes in psoriasis lesion skin and non-lesion skin tissues and three sets of RNA-seq data and analysed these online data attempting to screen for crucial genes related to keratinocyte proliferation and psoriasis development. The expression of CTNNBIP1 in psoriasis patients and IMQ mouse model skin tissues were examined by RT-PCR, immunoblotting and IHC. The functions of CTNNBIP1 on HaCaT cell proliferation, apoptosis and β-catenin/TCF complex were measured by MTT, EdU, flow cytometry, IF, luciferase assays and immunoblotting. RESULTS: The expression of catenin beta interacting protein 1 (CTNNBIP1) was remarkably downregulated within psoriasis lesion skin tissue samples compared to that within non-lesion skin tissues based on both online data and experimental results. In response to a period of different therapies, respectively, CTNNBIP1 expression could be rescued in lesion skin tissues. Within IMQ-induced psoriasis-like dermatitis in mice, CTNNBIP1 silence further aggravated psoriatic phenotypes. In human immortalized keratinocytes, HaCaT cells, CTNNBIP1 silence significantly inhibited cell apoptosis and promoted cell proliferation. Regarding the molecular mechanism, CTNNBIP1 silence in HaCaT cells promoted β-catenin nucleus translocation, enhanced the transcriptional activity of TCF4 and increased β-catenin/TCF complex downstream c-Myc and cyclin D1 proteins, and also increased the expression of cell proliferation marker ki-67. In contrast to CTNNBIP1, the expression of c-Myc and cyclin D1 showed to be dramatically upregulated within psoriasis lesion tissue samples than that within non-lesion tissue samples. Within tissues, c-Myc and cyclin D1 showed to be negatively correlated with CTNNBIP1, respectively. CONCLUSIONS: We identify CTNNBIP1 as an abnormally downregulated gene in psoriasis. CTNNBIP1 silence significantly disturbs the proliferation of keratinocytes through promoting the transcription of β-catenin/TCF complex downstream genes.
引用
- Wang C, Wang H, Peng Y, et al. CTNNBIP1 modulates keratinocyte proliferation through promoting the transcription of β-catenin/TCF complex downstream genes. J Eur Acad Dermatol Venereol. 2020. PMID: 32531088. doi:10.1111/jdv.16725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。